Geoffray Labar
Impact in
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
- Organic Chemistry top 10%
- Sulfur-Based Synthesis Techniques
- Synthesis and biological activity
- Synthesis and Reactivity of Sulfur-Containing Compounds
- Synthesis of β-Lactam Compounds
Papers in
- Pharmacology 14
- Cannabis and Cannabinoid Research 14
- Pharmacogenetics and Drug Metabolism 1
-
- RNA modifications and cancer 2
- Co-authors
- Didier M. Lambert (14 shared papers)Giulio G. Muccioli (9 shared papers)Johan Wouters (5 shared papers)Catherine Michaux (3 shared papers)Cédric Bauvois (2 shared papers)Jacques Henri Poupaert (3 shared papers)Franck Borel (1 shared paper)Jean-Luc Ferrer (1 shared paper)
In The Last Decade
Geoffray Labar
20 papers receiving 967 citations
Peers
Comparison fields: 5 of 51
- Pharmacology 433
- Organic Chemistry 141
- Biochemistry 17
- Pharmacology 16
- Computational Theory and Mathematics 26
Countries citing papers authored by Geoffray Labar
This map shows the geographic impact of Geoffray Labar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffray Labar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffray Labar more than expected).
Fields of papers citing papers by Geoffray Labar
This network shows the impact of papers produced by Geoffray Labar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffray Labar. The network helps show where Geoffray Labar may publish in the future.
Co-authors
The 25 scholars most cited alongside Geoffray Labar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 161 | |
| 2 | 2009 | 126 | |
| 3 | 2008 | 95 | |
| 4 | 2010 | 93 | |
| 5 | 2006 | 79 | |
| 6 | 2007 | 70 | |
| 7 | 2012 | 70 | |
| 8 | 2009 | 68 | |
| 9 | 2007 | 55 | |
| 10 | 2009 | 34 | |
| 11 | 2012 | 29 | |
| 12 | 2010 | 27 | |
| 13 | 2007 | 21 | |
| 14 | 2008 | 20 | |
| 15 | 2002 | 18 | |
| 16 | 2011 | 10 | |
| 17 | 2022 | 8 | |
| 18 | 2021 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2013 | 1 |
About Geoffray Labar
Geoffray Labar is a scholar working on Pharmacology, Pharmacology, Molecular Biology, Organic Chemistry and Nuclear Energy and Engineering, having authored 20 papers that have together received 992 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (14 papers), RNA modifications and cancer (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Synthesis of β-Lactam Compounds (1 paper). The work is most often cited by research in Pharmacology (433 citations), Organic Chemistry (141 citations), Biochemistry (17 citations), Pharmacology (16 citations) and Computational Theory and Mathematics (26 citations). Geoffray Labar has collaborated with scholars based in Belgium, France and Sweden. Frequent co-authors include Didier M. Lambert, Giulio G. Muccioli, Johan Wouters, Catherine Michaux, Cédric Bauvois, Jacques Henri Poupaert, Franck Borel, Jean-Luc Ferrer, Séverine Vandevoorde and Emma Persson. Their work appears in journals such as Journal of Medicinal Chemistry, ChemBioChem, RNA, Biochemical Pharmacology and Journal of Enzyme Inhibition and Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.